MPD: Phenotype measures mapped to MP:0003631, nervous system phenotype

Phenotype measures directly associated with ontology term
MP:0003631 'nervous system phenotype'

This list only includes measures mapped to MP:0003631 directly. Measures mapped to its ontology descendants are not included. Alternatively, you can show measures mapped to MP:0003631 AND its descendants.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Brich1:1	Brich1	metabolite quantification	(none)	tau phosphorylation level [score] level 12801	QTL population		f	3wks	N=51	2003

Chang1:1	Chang1	electroretinography	(none)	a-wave amplitude of rod photoreceptors (ERG) [µV] rod_Awave 15701	inbred	16	both	>7wks	N=15	2008

Chang1:2	Chang1	electroretinography	(none)	b-wave amplitude of rod photoreceptors (ERG) [µV] rod_Bwave 15702	inbred	17	both	>7wks	N=15	2008

Chang1:5	Chang1	electroretinography	(none)	b-wave amplitude of cone photoreceptors (ERG) [µV] cone_Bwave 15705	inbred	16	both	>7wks	N=14	2008

Chesler3:91	Chesler3	organ weights	(none)	brain weight [g] brain_wt 43591	CC pre w/par	181	both	7-15wks	N=1	2011

Crusio1:45	Crusio1	organ weights	(none)	brain weight [g] brain_wt 62045	BXD w/par	55	both	12-16wks	N=8	2018

Crusio1:46	Crusio1	organ weights	(none)	brain weight as percentage of total body weight [%] brain_wt_pct 62046	BXD w/par	55	both	12-16wks	N=8	2018

Crusio1:48	Crusio1	histopathology	(none)	total hippocampus size (arbitrary units) hippocampus 62048 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:50	Crusio1	histopathology	(none)	size of intra- and infrapyramidal mossy fibers (arbitrary units) iipmf 62050 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:52	Crusio1	histopathology	(none)	percentage of hippocampus that is Intra- and infrapyramidal mossy fibers [%] iipmf_pct 62052 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:55	Crusio1	histopathology	(none)	size of hilus (arbitrary units) hilus 62055 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:57	Crusio1	histopathology	(none)	percentage of hippocampus that is hilus [%] hilus_pct 62057 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:60	Crusio1	histopathology	(none)	size of suprapyramidal mossy fibers (arbitrary units) supra 62060 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:62	Crusio1	histopathology	(none)	percentage of hippocampus that is suprapyramidal mossy fibers [%] supra_pct 62062 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:65	Crusio1	histopathology	(none)	size of stratum pyramidale (arbitrary units) pyr 62065 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:67	Crusio1	histopathology	(none)	percentage of hippocampus that is stratum pyramidale [%] pyr_pct 62067 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:70	Crusio1	histopathology	(none)	size of stratum oriens (arbitrary units) oriens 62070 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:72	Crusio1	histopathology	(none)	percentage of hippocampus that is stratum oriens [%] oriens_pct 62072 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:75	Crusio1	histopathology	(none)	size of stratum radiatum (arbitrary units) rad 62075 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:77	Crusio1	histopathology	(none)	percentage of hippocampus that is stratum radiatum [%] rad_pct 62077 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:80	Crusio1	histopathology	(none)	size of stratum lacunosum-moleculare (arbitrary units) lacun 62080 left right	BXD w/par	55	both	12-16wks	N=4	2018

Crusio1:82	Crusio1	histopathology	(none)	percentage of hippocampus that is stratum lacunosum-moleculare [%] lacun_pct 62082 left right mean	BXD w/par	55	both	12-16wks	N=4	2018

Davidson1:1	Davidson1	health assessment	(none)	0=exencephaly, 1=normal [score] Exencephaly 19201	QTL population		both	embryo	N=94	2007

Davidson1:2	Davidson1	health assessment	(none)	1=exencephaly, 0=normal [score] Exen2 19202	QTL population		both	embryo	N=94	2007

Frankel1:1	Frankel1	electroconvulsion test	(none)	median critical current (CC₅₀) for minimal clonic seizure, frontal stimulation (at BH) [mA] E_MC_BH_FS 5601	inbred	4	m	6-11wks	N=35	2000

Frankel1:2	Frankel1	electroconvulsion test	(none)	median critical current (CC₅₀), transcorneal stimulation (at BH) [mA] E_MC_BH_TC 5602	inbred	16	both	6-11wks	N=33	2000

Frankel1:3	Frankel1	electroconvulsion test	(none)	median critical current (CC₅₀), transcorneal stimulation (at SL) [mA] E_MC_SL_TC 5603	inbred	8	both	6-11wks	N=29	2000

Frankel1:4	Frankel1	electroconvulsion test	(none)	median critical current (CC₅₀) for maximal tonic hindlimb extension seizure, frontal stimulation (at BH) [mA] E_MT_BH_FS 5604	inbred	4	m	6-11wks	N=44	2000

Frankel1:5	Frankel1	electroconvulsion test	(none)	median critical current (CC₅₀) for maximal tonic hindlimb extension seizure, transcorneal stimulation (at BH) [mA] E_MT_BH_TC 5605	inbred	16	both	6-11wks	N=38	2000

Frankel1:6	Frankel1	electroconvulsion test	(none)	median critical current (CC₅₀) for maximal tonic hindlimb extension seizure, transcorneal stimulation (at SL) [mA] E_MT_SL_TC 5606	inbred	8	both	6-11wks	N=29	2000

Frankel1:7	Frankel1	electroconvulsion test	(none)	median critical current (CC₅₀) for psychomotor seizure, frontal stimulation (at BH) [mA] E_PS_BH_FS 5607	inbred	4	m	6-11wks	N=41	2000

Frankel1:8	Frankel1	electroconvulsion test	(none)	median critical current (CC₅₀) for psychomotor seizure, transcorneal stimulation (at BH) [mA] E_PS_BH_TC 5608	inbred	14	both	6-11wks	N=41	2000

Frankel1:9	Frankel1	electroconvulsion test	(none)	median critical current (CC₅₀) for psychomotor seizure, transcorneal stimulation (at SL) [mA] E_PS_SL_TC 5609	inbred	7	both	6-11wks	N=39	2000

Frankel1:10	Frankel1	electroconvulsion test	lamotrigine	median effective dose (ED₅₀) against minimal clonic seizures (CC₉₇), transcorneal stimulation (at BH) [mg/kg] L_MC_BH_TC 5610	inbred	3	m	6-11wks	N=63	2000

Frankel1:12	Frankel1	electroconvulsion test	lamotrigine	median effective dose (ED₅₀) against minimal clonic seizures (CC₉₇), transcorneal stimulation (at SL) [mg/kg] L_MC_SL_TC 5612	inbred	3	m	6-11wks	N=51	2000

Frankel1:13	Frankel1	electroconvulsion test	lamotrigine	median effective dose (ED₅₀) against maximal tonic hindlimb extension seizure (CC₉₇), transcorneal stimulation (at BH) [mg/kg] L_MT_BH_TC 5613	inbred	3	m	6-11wks	N=52	2000

Frankel1:14	Frankel1	electroconvulsion test	lamotrigine	median effective dose (ED₅₀) against maximal tonic hindlimb extension seizure (CC₉₇), transcorneal stimulation (at SL) [mg/kg] L_MT_SL_TC 5614	inbred	3	m	6-11wks	N=45	2000

GMC05:31	GMC05	acoustic startle test	(none)	percent prepulse inhibition (PPI), 110 db sound pressure level [%] PPI 55431 67dB 69dB 73dB 81dB	inbred w/CC8	8	both	9-10wks	N=17	2018

GMC05:35	GMC05	acoustic startle test	(none)	percentage prepulse inhibition (PPI) evoked by 110 dB sound pressure level with global prepulse stimulus [%] PPI_global 55435	inbred w/CC8	8	both	9-10wks	N=17	2018

GMC05:51	GMC05	acoustic startle test	(none)	prepulse inhibition (PPI) [%] PPI_ISI 55451 inter-stimulus interval: 5 25 100	inbred w/CC8	8	both	9-10wks	N=17	2018

JaxKOMP-EAP:187	JaxKOMP-EAP	acoustic startle test	(none)	average percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] avg_ppi pct_ppi_ppN_avg 100517 pp1 pp2 pp3	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:194	JaxKOMP-EAP	acoustic startle test	(none)	corrected average percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] avg_corrected_ppi corrected_percent_ppN_avg 100526 74 dB 78 dB 82 dB	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:197	JaxKOMP-EAP	acoustic startle test	(none)	average of each corrected percent pre-pulse inhibition value [%] avg_corrected_ppi_global corrected_ppi_global_avg 100530	KOMP	1786	both	10wks	N=8	2021

JaxKOMP-EAP:202	JaxKOMP-EAP	acoustic startle test	(none)	maximum startle response to full pulse (120 dB) [mV] max_s s 100549	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:209	JaxKOMP-EAP	acoustic startle test	(none)	average of maximum percent pre-pulse inhibition for each pre-pulse tested [%] max_ppi_global pct_ppi_global 100543	KOMP	381	both	10wks	N=8	2021

JaxKOMP-EAP:214	JaxKOMP-EAP	acoustic startle test	(none)	corrected maximum percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] max_corrected_ppi corrected_percent_ppN_vmax 100555 pp1 pp2 pp3	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:217	JaxKOMP-EAP	acoustic startle test	(none)	average of each corrected maximum percent pre-pulse inhibition value [%] max_corrected_ppi_global corrected_ppi_global_vmax 100559	KOMP	1788	both	10wks	N=8	2021

JaxKOMP-EAP:295	JaxKOMP-EAP	ophthalmoscopy	(none)	optic disc optic_disc 100620 categorical	KOMP	2025	both	14wks		2021

JaxKOMP-EAP:364	JaxKOMP-EAP	electroretinography	(none)	b-wave amplitude of cone photoreceptors [µV] cone_b_amplitude cone_b_wave_amplitude 100314 left right	KOMP	351	both	16wks	N=3	2016

JaxKOMP-EAP:366	JaxKOMP-EAP	electroretinography	(none)	b-wave implicit time of rod photoreceptors (interval from onset of stimulus to peak of the wave) [ms] cone_b_time cone_b_wave_implicit_time 100316 left right	KOMP	338	both	16wks	N=3	2016

JaxKOMP-EAP:368	JaxKOMP-EAP	electroretinography	(none)	a-wave amplitude of rod photoreceptors [µV] rod_a_amplitude rod_a_wave_amplitude 100318 left right	KOMP	356	both	16wks	N=3	2016

JaxKOMP-EAP:370	JaxKOMP-EAP	electroretinography	(none)	rod a wave implicit time rod_a_time rod_a_wave_implicit_time 100320 left right	KOMP	330	both	16wks	N=3	2016

JaxKOMP-EAP:372	JaxKOMP-EAP	electroretinography	(none)	b-wave amplitude of rod photoreceptors [µV] rod_b_amplitude rod_b_wave_amplitude 100322 left right	KOMP	357	both	16wks	N=3	2016

JaxKOMP-EAP:374	JaxKOMP-EAP	electroretinography	(none)	rod b wave implicit time rod_b_time rod_b_wave_implicit_time 100324 left right	KOMP	346	both	16wks	N=3	2016

JaxKOMP-EAP:399	JaxKOMP-EAP	electroconvulsion test	(none)	applied stimulus (current), by day [mA] current ma 100783 day: 1 2 3 4 5 6 7 8 9 10	KOMP	23	both	17wks	N=8	2016

JaxKOMP-EAP:409	JaxKOMP-EAP	electroconvulsion test	(none)	behavior following applied stimulus (current), by day [score] score 100784 day: 1 2 3 4 5 6 7 8 9 10	KOMP	448	both	17wks	N=9	2016

JaxKOMP-EAP:419	JaxKOMP-EAP	electroconvulsion test	(none)	stimulus level (current) required for minimal clonic forebrain seizure (score of 3 or higher) [mA] threshold ma_threshold 100813	KOMP	479	both	17wks	N=9	2016

JaxKOMP-LAP:176	JaxKOMP-LAP	acoustic startle test	(none)	average percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] avg_ppi pct_ppi_ppN_avg 101517 pp1 pp2 pp3	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:183	JaxKOMP-LAP	acoustic startle test	(none)	corrected average percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] avg_corrected_ppi corrected_percent_ppN_avg 101526 74 dB 78 dB 82 dB	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:186	JaxKOMP-LAP	acoustic startle test	(none)	average of each corrected percent pre-pulse inhibition value [%] avg_corrected_ppi_global corrected_ppi_global_avg 101530	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:191	JaxKOMP-LAP	acoustic startle test	(none)	maximum startle response to full pulse (120 dB) [mV] max_s s 101549	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:196	JaxKOMP-LAP	acoustic startle test	(none)	average of maximum percent pre-pulse inhibition for each pre-pulse tested [%] max_ppi_global pct_ppi_global 101543	KOMP		both	68-72wks		2018

JaxKOMP-LAP:201	JaxKOMP-LAP	acoustic startle test	(none)	corrected maximum percent pre-pulse inhibition to full pulse (120 dB) preceded by pre-pulse [%] max_corrected_ppi corrected_percent_ppN_vmax 101555 pp1 pp2 pp3	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:204	JaxKOMP-LAP	acoustic startle test	(none)	average of each corrected maximum percent pre-pulse inhibition value [%] max_corrected_ppi_global corrected_ppi_global_vmax 101559	KOMP	3	both	68-72wks	N=9	2018

JaxKOMP-LAP:268	JaxKOMP-LAP	ophthalmoscopy	(none)	optic disc optic_disc 101620 categorical	KOMP	150	both	72-79wks		2021

Jaxpheno2:1	Jaxpheno2	organ weights	(none)	brain weight [g] brain 22701 age 8wks age 16wks	inbred	11	both		N=8	2006

Jaxpheno2:3	Jaxpheno2	organ weights	(none)	brain weight as percentage of body weight [%] pct_brain 22703 age 8wks age 16wks	inbred	11	both		N=8	2006

Kas1:1	Kas1	microscopy	(none)	size, area of total ventral root [µm²] area_ventral_root 34401	inbred	6	m	22-31wks	N=4	2009

Kas1:2	Kas1	microscopy	(none)	number of axons per ventral root (calculated) [n] total_axon 34402	inbred	6	m	22-31wks	N=4	2009

Kas1:3	Kas1	microscopy	(none)	size, area of median axon [µm²] area_median_axon 34403	inbred	6	m	22-31wks	N=6	2009

Kas1:4	Kas1	microscopy	(none)	percent of 0-50 µm² axons [%] pct_axon50 34404	inbred	6	m	22-31wks	N=6	2009

Kas1:5	Kas1	microscopy	(none)	percent of 50-100 µm² axons [%] pct_axon100 34405	inbred	6	m	22-31wks	N=6	2009

Kas1:6	Kas1	microscopy	(none)	percent of 100-150 µm² axons [%] pct_axon150 34406	inbred	6	m	22-31wks	N=6	2009

Kas1:7	Kas1	microscopy	(none)	percent of 150-200 µm² axons [%] pct_axon200 34407	inbred	6	m	22-31wks	N=6	2009

Kas1:14	Kas1	microscopy	(none)	number of axons per region of interest (6000 µm²) [n] axon 34414	inbred	6	m	22-31wks	N=6	2009

Klaassen1:3	Klaassen1	histopathology	cadmium	cadmium-induced toxicity to trigeminal ganglia [designation] ganglia 16403 categorical	inbred	8	m	8wks		2001

Marchuk1:1	Marchuk1	histopathology	(none)	infarct volume following surgically-induced focal cerebral ischemia [mm³] infarct_vol 45001	inbred	16	both	11-13wks	N=4	2009

Molenhuis1:8	Molenhuis1	organ weights	(none)	brain weight [g] brain_wt 110075	CC	52	m	7-20wks	N=5	2018

Neuner1:9	Neuner1	biomarker quantification	(none)	temporal cortex amyloid level (ng/mg total protein) [ng/mg] amyloid 65909 6 mo 14 mo	F1 AD-BXD	23	both	23-57wks	N=2	2019

Palmer3:32	Palmer3	acoustic startle test	(none)	percentage prepulse inhibition (PPI) evoked by 120 dB sound pressure level with 6 dB prepulse stimulus [%] PPI 59232	F1 Tcf7l2	30	both	7-14wks	N=5	2017

Palmer5:32	Palmer5	acoustic startle test	(none)	percentage prepulse inhibition (PPI) evoked by 120 dB sound pressure level with 6 dB prepulse stimulus [%] PPI 59732	F1 Tcf7l2	30	both	7-14wks	N=5	2017

Petryshen1:7	Petryshen1	acoustic startle test	(none)	percent prepulse inhibition (PPI) evoked by 120 dB tone [%] PPI 34707 70dB 75dB 80dB 85dB	B6.A consomic	22	m	7-9wks	N=23	2009

Poon1:1	Poon1	histopathology	(none)	BrdU+ cells of rostral migratory stream [n/mm] RMS 47501 3mo 12mo 18mo	inbred	9	both		N=3	2013

Reed2:31	Reed2	organ weights	(none)	brain weight [g] brain_wt 53131	B6.129 and 129.B6 consomic w/par	9	both	26wks	N=17	2015

Rhodes1:3	Rhodes1	microscopy	exercise	hippocampus: volume of dentate gyrus [mm³] DG_vol 34603 control with running wheel	inbred	12	both	15wks	N=4	2010

Rhodes1:5	Rhodes1	microscopy	exercise	hippocampus: number of new neurons in dentate gyrus [n] DG_neurons 34605 control with running wheel	inbred	12	both	15wks	N=4	2010

Rhodes1:7	Rhodes1	microscopy	exercise	hippocampus: density of new neurons in dentate gyrus [n/mm³] DG_density 34607 control with running wheel	inbred	12	both	15wks	N=4	2010

Richfield1:23	Richfield1	neurotransmitter quantification	(none)	3,4-dihydroxyphenylacetic acid (DOPAC), ng per mg total protein [ratio] DOPAC 14523	inbred	15	m	7-9wks	N=10	2003

Richfield1:24	Richfield1	neurotransmitter quantification	(none)	4-hydroxy-3-methoxyphenylacetic acid (HVA), ng per mg total protein [ratio] HVA 14524	inbred	15	m	7-9wks	N=10	2003

Richfield1:25	Richfield1	neurotransmitter quantification	(none)	serotonin (5HT), ng per mg total protein [ratio] 5HT 14525	inbred	15	m	7-9wks	N=10	2003

Rosen1:1	Rosen1	histopathology	(none)	corpus callosum area [mm²] corpus_callosum 47801	BXD w/par	78	both	varies	N=2	2012

Rosen1:2	Rosen1	histopathology	(none)	corpus callosum area, adjusted [mm²] corpus_callosum_adj 47802	BXD w/par	78	both	varies	N=2	2012

Rosen2:1	Rosen2	histopathology	(none)	lateral septum volume [mm³] lateral_septum 47901	BXD w/par	71	both	varies	N=3	2012

Rosen2:2	Rosen2	histopathology	(none)	lateral septum volume, adjusted [mm³] lateral_septum_adj 47902	BXD w/par	71	both	varies	N=2	2012

Schalkwyk2:1	Schalkwyk2	RNA expression profiling	(none)	miR-15b, hippocampal microRNA expression, relative miR15b 48101	BXD w/par	26	m	15-16wks	N=4	2012

Schalkwyk2:2	Schalkwyk2	RNA expression profiling	(none)	miR-31, hippocampal microRNA expression, relative miR31 48102	BXD w/par	26	m	15-16wks	N=4	2012

Schalkwyk2:3	Schalkwyk2	RNA expression profiling	(none)	miR-34c, hippocampal microRNA expression, relative miR34c 48103	BXD w/par	26	m	15-16wks	N=4	2012

Schalkwyk2:4	Schalkwyk2	RNA expression profiling	(none)	miR-212, hippocampal microRNA expression, relative miR212 48104	BXD w/par	26	m	15-16wks	N=4	2012

Schalkwyk2:5	Schalkwyk2	RNA expression profiling	(none)	miR-301a, hippocampal microRNA expression, relative miR301a 48105	BXD w/par	26	m	15-16wks	N=4	2012

Schauwecker1:1	Schauwecker1	health assessment	pilocarpine	pilocarpine dose required to induce status epilepticus, mg/kg body weight [mg/kg] ED100 47701	inbred	8	m	8-10wks	N=4	2012

Schauwecker1:2	Schauwecker1	health assessment	pilocarpine	latency to onset of stage 4 status epilepticus seizures [min] latency 47702	inbred	8	m	8-10wks	N=4	2012

Schauwecker1:3	Schauwecker1	health assessment	pilocarpine	duration of stage 4 status epilepticus seizures [min] duration 47703	inbred	8	m	8-10wks	N=4	2012

Schauwecker1:4	Schauwecker1	health assessment	pilocarpine	status epilepticus seizure mortality (0=died; 1=survived) [designation] survival 47704	inbred	11	m	8-10wks	N=18	2012

Spijker1:13	Spijker1	acoustic startle test	(none)	prepulse inhibition (PPI), 120 dB startle intensity [%] PPI 40613 120 dB startle intensity with prepulse stimulus: 65dB 70dB 75dB 80dB	BXD w/par	36	m	8wks	N=9	2011

Spijker1:17	Spijker1	acoustic startle test	(none)	prepulse intensity 10 dB lower than startle threshold [amplitude] PPI_belowST 40617	BXD w/par	36	m	8wks	N=9	2011

Tsaih1:2	Tsaih1	organ weights	(none)	mean of the brain weight in each line mean_brain 18102	QTL population		both		N=106	2005

Wahlsten1:4	Wahlsten1	organ weights	(none)	brain weight, after fixation and trimming [g] brain_wt 10804 weight as percent of body weight	inbred	21	both	12wks	N=10	2003

Wahlsten1:6	Wahlsten1	histopathology	(none)	length of corpus callosum at mid-sagittal plane [mm] cc_length 10806	inbred	21	both	12wks	N=10	2003

Wahlsten1:7	Wahlsten1	histopathology	(none)	length of hippocampal commissure at mid-sagittal plane [mm] hc_length 10807	inbred	21	both	12wks	N=10	2003

Wahlsten1:8	Wahlsten1	histopathology	(none)	length of anterior commissure at mid-sagittal plane [mm] ac_length 10808	inbred	21	both	12wks	N=10	2003

Wahlsten1:9	Wahlsten1	histopathology	(none)	cross-sectional area of corpus callosum at midplane [mm²] cc_area 10809	inbred	21	both	12wks	N=10	2003

Wahlsten1:10	Wahlsten1	histopathology	(none)	cross-sectional area of hippocampal commissure at midplane [mm²] hc_area 10810	inbred	21	both	12wks	N=10	2003

Wahlsten1:11	Wahlsten1	histopathology	(none)	cross-sectional area of anterior commissure at midplane [mm²] ac_area 10811	inbred	21	both	12wks	N=10	2003

Wahlsten1:12	Wahlsten1	histopathology	(none)	corpus callosum index (0=absent, 1=normal, <0.65 is abnormal) [score] cc_index 10812	inbred	21	both	12wks	N=10	2003

Wahlsten1:13	Wahlsten1	histopathology	(none)	hippocampal commissure index (0=absent, 1=normal, <0.5 is abnormal) [score] hc_index 10813	inbred	21	both	12wks	N=10	2003

Wahlsten1:14	Wahlsten1	histopathology	(none)	anterior commissure index (0=absent, 1=normal, <.60 is abnormal) [score] ac_index 10814	inbred	21	both	12wks	N=10	2003

Willott1:8	Willott1	acoustic startle test	(none)	mean prepulse inhibition (PPI), 70dB [ratio] PPI 9108 4kHz 12kHz 20kHz all tones	inbred w/CC7	40	both	5-6wks	N=10	2002

Filter Table Results